Where Tech Meets Bio
Latest News
OpenAI and Retro Biosciences have released new findings from a joint effort in AI-driven protein engineering. Using GPT-4b micro, a biology-specialized variant of GPT-4o, the …
Read More
Immunai Opens Free Single-Cell Sequencing Program for Academic Labs
Immunai, a New York–based company specializing in AI-driven immune system mapping, has announced a program offering academic researchers free access to its single-cell immune profiling …
Read More
KYORIN Pharmaceutical Adopts AI Drug Discovery Platform From Elix
KYORIN Pharmaceutical has adopted Elix Discovery, an AI-based drug discovery platform developed by Tokyo-based Elix. The system is designed to accelerate early-stage research by applying …
Read More
Latest News
Innovatrix and Opyl Partner to Launch AI-Driven Insurance for Clinical Trial Failure
Ginkgo, Inductive Bio, and Tangible Scientific Connect AI Models with Automated Labs for Drug Discovery
Silicon Valley’s Molecular Devices Brings AI to Brain Organoid Culture
Owkin to Bring Agentic AI into Vienna’s Oncology Ecosystem
Generative AI Designs Novel Antibiotics Against MRSA and Drug-Resistant Gonorrhea
BioAge Labs Begins Phase 1 Trial of Oral NLRP3 Inhibitor for Obesity
Latest Insights
by BiopharmaTrend
Novotech Report: Over 800 Global IPF Trials Since 2020, Led by Asia-Pacific
Novotech CRO has released a global market analysis focused on the clinical trial landscape for Idiopathic Pulmonary Fibrosis (IPF), identifying strategic trends for drug developers …
Read More
by Dominik Tomicevic
How AI, Graphs, and GraphRAG Are Set to Revolutionize Alzheimer's Gene Research and Treatment
An estimated 6.9 million Americans aged 65 and older are living with Alzheimer’s. Without major medical breakthroughs, that number is projected to rise to 13.8 …
Read More
How AI Is Transforming Medicinal Chemistry Between Discovery and Manufacture
by Andrii Buvailo, PhD
"AI Scientists" - New Collaborators for Rare Disease Research?
by Louise von Stechow
What are Foundation Models in Biology and Healthcare?
by BiopharmaTrend
The Pivotal Role of AI in Clinical Trials: From Digital Twins to Synthetic Control Arms
by BiopharmaTrend
Building AI Solutions for Life Sciences and Healthcare
by BiopharmaTrend
Into the Unknown — How Artificial Intelligence Can Help Biotech Companies Chart the Dark Genome
by Louise von Stechow
Beyond Legacy Tools: Defining Modern AI Drug Discovery for 2025 and Beyond
by Andrii Buvailo, PhD, Oleg Kucheriavyi, PhD
AI-Based Next-Generation-Phenotyping for Rare Disease Diagnosis
by Adele Ruder, Alexander Hustinx, Louise von Stechow
From Our Partners
Sponsored by
OPTIC
AI Is Key to Democratizing Drug Discovery
Sponsored by
MEDSIR
Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs and Precision Medicine in Oncology
Sponsored by
SpiroChem
Chemistry CROs at a Crossroads: How SpiroChem Is Adapting to Market Shifts in 2025 and Beyond
Sponsored by
Intelligencia AI
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Partner Events

Drug Discovery Innovation Programme
Event Date: Sept. 25, 2025 - Sept. 26, 2025
Location: Spain (InterContinental Barcelona, Spain)
Website: Link
Promo Code: YOUSAVE15 (valid till 2025-08-15)
Read more ›››

RNA Leaders USA Congress
Event Date: Sept. 10, 2025 - Sept. 11, 2025
Location: United States of America (Boston Exhibition & Convention Center)
Website: Link
Promo Code: MMBioPharmaTrend15
Read more ›››

The 12th Aging Research & Drug Discovery Meeting
Event Date: Aug. 25, 2025 - Aug. 29, 2025
Location: Denmark (Ceremonial Hall, University of Copenhagen)
Website: Link

Interactive Response Technologies 2025
Event Date: Oct. 14, 2025 - Oct. 15, 2025
Location: United States of America (The Westin Copley Place, Boston, MA)
Website: Link
Promo Code: IRT25BPT
Read more ›››
Case Studies
Sponsored by
BenchSci
From Data to Discovery: How BenchSci’s ASCEND Builds a Map for Biomedical Reasoning
Sponsored by
Trialize
Revolutionizing Clinical Trials: How AI and Automation Reduced Study Build Time from Months to Days
Sponsored by
RECEPTOR.AI
AI Becomes a Drop-in Replacement for Docking
Sponsored by
RECEPTOR.AI
Busting the PoseBusters v3: AI Docking Software ArtiDock Beats Industry’s State of the Art in Speed and Accuracy
Sponsored by
RECEPTOR.AI
ArtiDock from Receptor.AI: Next-generation AI Docking That Beats DiffDock and AlphaFold-latest
Sponsored by
Lantern Pharma
Powering Cancer Drug Discovery and Development Using the Artificial Intelligence and Machine Learning Platform RADR®
Sponsored by
Arctoris
Using End-to-End Wet Lab Automation Combined with Machine Learning to Industrialize Drug Discovery
Sponsored by
Kymera Therapeutics
Identifying High Impact Tissue Sparing E3 Ligases and Their Binders
Interviews
Merging AI and Quantum Computing To Boost Drug Discovery
This South Korean Company is at the Forefront of AI-driven Drug Discovery
Alex Zhavoronkov: Linking Chemistry and Biology Using Artificial Intelligence
Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs and Precision Medicine in Oncology
Most Read
Artificial Intelligence
The Growing Impact of AI in Healthcare
--
Hunting Cancer Before It Can Hunt You: A Bird's Eye View of Cell-Free DNA Market Trends
Artificial Intelligence
Insilico Medicine’s Generative AI Patent Provides Advantage in AI Drug Discovery Race
--
7 Promising RNA Biotech Companies To Watch in 2024